Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Knight Therapeutics Inc
(OP:
KHTRF
)
4.099
-0.001 (-0.02%)
Streaming Delayed Price
Updated: 11:18 AM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,045
Open
4.100
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
4.100
Today's Range
4.099 - 4.100
52wk Range
3.260 - 4.550
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Is Ardelyx is A Buy After Slip in Early 2022
November 21, 2022
Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them
Via
MarketBeat
Exposures
Product Safety
Knight Therapeutics Secures Rights To Rigel's Fostamatinib In Latin America
May 24, 2022
Knight Therapeutics Inc. (TSX: GUD) (OTC: KHTRF)
Via
Benzinga
Performance
YTD
+5.75%
+5.75%
1 Month
-8.91%
-8.91%
3 Month
+0.22%
+0.22%
6 Month
-2.17%
-2.17%
1 Year
+24.97%
+24.97%
More News
Read More
Puma Biotech's Nerlynx Wins Canadian Approval In HER2-Positive Metastatic Breast Cancer
July 06, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.